Zhengye Biotechnology Holding Ltd
Filed with the SEC on · accession 0001213900-26-118931
ZYBT filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved -1.3% by the first close after the filing.
Zhengye Biotechnology Holding Ltd filed its Form 6-K containing unaudited interim financial statements for the six months ended June 30, 2026, along with related disclosures on bank borrowings, subsequent events, and share reclassification.
Close before
$1.52
Nov 11, 2026
First close after
-1.32%
$1.50
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ZYBT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZYBT?
Click hereZYBT filed a 6-K (SEC filing). Zhengye Biotechnology Holding Ltd filed its Form 6-K containing unaudited interim financial statements for the six months ended June 30, 2026, along with related disclosures on bank borrowings, subsequent events, and share reclassification.
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
ZYBT closed at $1.52 before the filing and $1.50 on Nov 12, 2026 (-1.32%).
Get alerts when ZYBT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days